The fluorescentproductproduced in theAmplexRedassay is called______.Our assaydirectlymeasureshydrogen______ levels.Whichhypertensiveanimal modeldid we use?___________Neutralizingantibodiestargetedactivin A and______.Follistatinincreases theexpression of______, which iscritical for nitricoxide production.Follistatinretains itsantioxidanteffect evenwhen denatured.True/FalseWhich type of assayis used to evaluateNO levels in ourstudy: fluorometricor colorimetric? _____________Follistatintreatment induces______ of PVAT, aphenotypeassociated withimproved vascularfunction.Follistatin isknown toneutralizesignaling by______.FST lowersROS levels, asindicated by adecrease in______ levels.Follistatinmust maintainits proper______ to befunctional.In our study,follistatin wasadministered toSHRs over aperiod of______ weeks.FST wasadministeredevery______ day.What is theendogenousprotein we studiedthat antagonizesactivin?_____________"In our experiments,the reduction inoxidative stress wasmeasured as adecrease in the foldchange of ______.Which proteinmarker indicatesa brown adiposephenotype inPVAT?_____________Enhanced NObioavailabilityindicatesimproved______.Our study showsthat blockingactivin signalingreduces ______production.FST’santioxidanteffect is lostif it is______.Whichnormotensivestrain served asour control?_____________What assay didwe use toquantifyhydrogenperoxide?_____________Hypertension isdefined bysustained bloodpressure above____ mmHg.Follistatintreatmentreduced bloodpressure byapproximately______ mmHg.What does theabbreviation'SHR' stand for? _____________The fluorescentproductproduced in theAmplexRedassay is called______.Our assaydirectlymeasureshydrogen______ levels.Whichhypertensiveanimal modeldid we use?___________Neutralizingantibodiestargetedactivin A and______.Follistatinincreases theexpression of______, which iscritical for nitricoxide production.Follistatinretains itsantioxidanteffect evenwhen denatured.True/FalseWhich type of assayis used to evaluateNO levels in ourstudy: fluorometricor colorimetric? _____________Follistatintreatment induces______ of PVAT, aphenotypeassociated withimproved vascularfunction.Follistatin isknown toneutralizesignaling by______.FST lowersROS levels, asindicated by adecrease in______ levels.Follistatinmust maintainits proper______ to befunctional.In our study,follistatin wasadministered toSHRs over aperiod of______ weeks.FST wasadministeredevery______ day.What is theendogenousprotein we studiedthat antagonizesactivin?_____________"In our experiments,the reduction inoxidative stress wasmeasured as adecrease in the foldchange of ______.Which proteinmarker indicatesa brown adiposephenotype inPVAT?_____________Enhanced NObioavailabilityindicatesimproved______.Our study showsthat blockingactivin signalingreduces ______production.FST’santioxidanteffect is lostif it is______.Whichnormotensivestrain served asour control?_____________What assay didwe use toquantifyhydrogenperoxide?_____________Hypertension isdefined bysustained bloodpressure above____ mmHg.Follistatintreatmentreduced bloodpressure byapproximately______ mmHg.What does theabbreviation'SHR' stand for? _____________

Follistatin to the Rescue: Bingo for Lowering Pressure and Defeating ROS - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. The fluorescent product produced in the AmplexRed assay is called ______.
  2. Our assay directly measures hydrogen ______ levels.
  3. Which hypertensive animal model did we use? ___________
  4. Neutralizing antibodies targeted activin A and ______.
  5. Follistatin increases the expression of ______, which is critical for nitric oxide production.
  6. Follistatin retains its antioxidant effect even when denatured. True/False
  7. Which type of assay is used to evaluate NO levels in our study: fluorometric or colorimetric? _____________
  8. Follistatin treatment induces ______ of PVAT, a phenotype associated with improved vascular function.
  9. Follistatin is known to neutralize signaling by ______.
  10. FST lowers ROS levels, as indicated by a decrease in ______ levels.
  11. Follistatin must maintain its proper ______ to be functional.
  12. In our study, follistatin was administered to SHRs over a period of ______ weeks.
  13. FST was administered every ______ day.
  14. What is the endogenous protein we studied that antagonizes activin? _____________
  15. "In our experiments, the reduction in oxidative stress was measured as a decrease in the fold change of ______.
  16. Which protein marker indicates a brown adipose phenotype in PVAT? _____________
  17. Enhanced NO bioavailability indicates improved ______.
  18. Our study shows that blocking activin signaling reduces ______ production.
  19. FST’s antioxidant effect is lost if it is ______.
  20. Which normotensive strain served as our control? _____________
  21. What assay did we use to quantify hydrogen peroxide? _____________
  22. Hypertension is defined by sustained blood pressure above ____ mmHg.
  23. Follistatin treatment reduced blood pressure by approximately ______ mmHg.
  24. What does the abbreviation 'SHR' stand for? _____________